Biohub raises $1.8bn for its 'virtual biology' initiative
Just months after launching an open-source 'virtual biology' platform, Biohub has raised $1.8 billion in backing for the AI-powered initiative.
Newsletters and Deep Dive digital magazine
Just months after launching an open-source 'virtual biology' platform, Biohub has raised $1.8 billion in backing for the AI-powered initiative.
Reliance on US big tech is now being challenged around the world at a time when geopolitical instability is eroding global trust in US leadership.
Click Therapeutics has won the first-ever FDA approval for a treatment for the negative symptoms of schizophrenia, a DTx called Motivista.
The UK will accept all 44 proposals made in a recent report on using AI tools in the NHS, including continuous monitoring after deployment.
Axtria HIQ is an agentic analytics product built specifically for pharmaceutical headquarters teams.
Editor's Picks
Newsletters and Deep Dive
digital magazine